Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) as a prognostic biomarker of poor outcomes in esophageal cancer patients.

BMC gastroenterology - 23 Feb 2021

Kuerbanjiang Aihemaijiang, Maimaituerxun Maimaitiyiming, Zhang Yanjun, Li Yiliang, Cui Gang, Abuduhabaier Aibaidula, Aierken Abuduwaili, Miranbieke Buya, Anzaer Meilikezati, Maimaiti Yusufu

Abstract excerpt

BACKGROUND: Esophageal cancer is one of the most aggressive malignancies, and is associated with multiple genetic mutations. At present, the v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) gene mutation has been observed in esophageal cancer and is associated with poor prognosis. This study aimed to investigate the protein expression of BRAF in esophageal cancer and determine its effect on patient outcomes....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Esophageal Neoplasms

Share to Mice, Nude

Share to Oncogenes

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Source

Open in PubMed Open full text

Identifiers

PMID: 33622273
DOI: 10.1186/s12876-021-01671-2
PMCID: PMC7903799

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) as a prognostic biomarker of poor outcomes in esophageal cancer patients.PMID 33622273Read ↗

FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patientsSemantic proximity Read ↗

Clinicopathological findings of primary esophageal malignant melanoma: report of six cases and review of literature.Semantic proximity Read ↗

The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis.Semantic proximity Read ↗

ETV5 overexpression promotes progression of esophageal squamous carcinoma by upregulating SKA1 and TRPV2Semantic proximity Read ↗

Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma.Semantic proximity Read ↗

Targeted therapy in esophageal cancer.Semantic proximity Read ↗

Extracellular vesicle-mediated gene therapy targets BRAFV600E-mutant colorectal cancer by inhibiting the MEK1/2-ERK1/2 pathwaySemantic proximity Read ↗

FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.Semantic proximity Read ↗

Establishment and characterization of urothelial carcinoma cell lines with and without BRAF mutation (V595E) in dogs.Semantic proximity Read ↗

No evidence for BRAF-V600E mutations in gastroeosophageal tumors: results from a high-throughput analysis of 534 cases using a mutation-specific antibody.Semantic proximity Read ↗

miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2Semantic proximity Read ↗

Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.